Treatment Guidelines for Castleman Disease Applicable in Clinical Practice
An evaluation of guidelines for idiopathic multicentric Castleman disease supports use of IL-6 agents as first-line treatment.
Read More
Ad Code: Iptacopan - Rare Blood Disorders - NOV Display Banners HCP Wallboard Extension - 61024
Castleman Disease Diminishes Daily Life for Patients & Caregivers
High symptom burden negatively impacted several aspects of daily life for patients with idiopathic multicentric Castleman Disease (iMCD) and their caregivers, according to findings published in eClinicalMedicine. John Brazier,...
Read MorePNH Clone, Age & Gender Influence Survival in Aplastic Anemia
In non-severe aplastic anemia, the presence of a paroxysmal nocturnal hemoglobinuria (PNH) clone was positively associated with survival, while age was negatively associated with survival, according to results published in...
Read More